Literature DB >> 33517829

The role of social determinants in timely herpes zoster vaccination among older American adults.

Sohul Shuvo1, Tracy Hagemann2, Kenneth Hohmeier2, Chi-Yang Chiu3, Sujith Ramachandran4, Justin Gatwood2.   

Abstract

CDC recommends that U.S. adults ≥50 years receive the herpes zoster (HZ) vaccine; but few are vaccinated at the recommended age. Little is known about how social determinants of health (SDH) influence timely vaccination. This retrospective observational study included U.S. adults aged ≥50 years who were vaccinated against HZ between 2014 and 2016 from IBM MarketScan commercial claims and Medicare supplemental databases. The cohort was classified into three groups based on age of vaccination: earlier (50-59 years), timely (60-64 years), and later (65+ years). Select SDH data from publicly-available sources were linked and included in multinomial logistic regression assessing the impact of SDH on timely vaccination. The final cohort comprised 549,544 individuals, 49.5% of whom were vaccinated at the age of 60-64. Odds of later HZ vaccination increased with higher poverty (OR: 1.035, 95% CI: 1.031-1.038), more democratic voters (OR: 1.011, 95% CI: 1.010-1.012), and lack of Internet access (OR: 1.028, 95% CI: 1.024-1.032), but decreased with higher health literacy (OR: 0.971, 95% CI: 0.970-0.973). Conversely, higher health literacy and lower poverty were associated with higher odds of earlier vaccination. Being male, not receiving a seasonal influenza vaccine, and higher healthcare utilization were associated with later vaccination. Individuals on an EPO/PPO vs. HMO plan, or who resided in regions other than the Northeast were more likely to receive the vaccine earlier. This study demonstrates the influence of SDH on time of HZ vaccination, but further research is needed to fully understand the impact of SDH on vaccination.

Entities:  

Keywords:  Adult vaccination; herpes zoster; preventive medicine; social determinants; vaccine hesitancy

Mesh:

Substances:

Year:  2021        PMID: 33517829      PMCID: PMC8189134          DOI: 10.1080/21645515.2020.1856598

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  22 in total

1.  Trends and disparity in zoster vaccine uptake in a managed care population.

Authors:  Rulin C Hechter; Sara Y Tartof; Steven J Jacobsen; Ning Smith; Hung Fu Tseng
Journal:  Vaccine       Date:  2013-08-05       Impact factor: 3.641

2.  Vaccine hesitancy: Definition, scope and determinants.

Authors:  Noni E MacDonald
Journal:  Vaccine       Date:  2015-04-17       Impact factor: 3.641

3.  Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.

Authors:  Angela K Shen; Rob Warnock; Weston Selna; Thomas E MaCurdy; Steve Chu; Jeffrey A Kelman
Journal:  Vaccine       Date:  2019-01-22       Impact factor: 3.641

Review 4.  Countering Vaccine Hesitancy.

Authors:  Kathryn M Edwards; Jesse M Hackell
Journal:  Pediatrics       Date:  2016-09       Impact factor: 7.124

5.  Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.

Authors:  Benjamin S Teeter; Kimberly B Garza; T Lynn Stevenson; Margaret A Williamson; Megan L Zeek; Salisa C Westrick
Journal:  Vaccine       Date:  2014-08-27       Impact factor: 3.641

6.  Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Rafael Harpaz; Ismael R Ortega-Sanchez; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2008-06-06

Review 7.  Herpes zoster and postherpetic neuralgia in older adults.

Authors:  Kenneth Schmader
Journal:  Clin Geriatr Med       Date:  2007-08       Impact factor: 3.076

Review 8.  Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data.

Authors:  Jason M Nagata; Isabel Hernández-Ramos; Anand Sivasankara Kurup; Daniel Albrecht; Claudia Vivas-Torrealba; Carlos Franco-Paredes
Journal:  BMC Public Health       Date:  2013-04-25       Impact factor: 3.295

9.  Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.

Authors:  Kathleen L Dooling; Angela Guo; Manisha Patel; Grace M Lee; Kelly Moore; Edward A Belongia; Rafael Harpaz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-26       Impact factor: 17.586

10.  An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability.

Authors:  Elizabeth M La; Laurel Trantham; Samantha K Kurosky; Dawn Odom; Emmanuel Aris; Cosmina Hogea
Journal:  Hum Vaccin Immunother       Date:  2017-12-15       Impact factor: 3.452

View more
  4 in total

1.  Health Literacy, Socioeconomic Status and Vaccination Uptake: A Study on Influenza Vaccination in a Population-Based Sample.

Authors:  Patrizio Zanobini; Chiara Lorini; Saverio Caini; Vieri Lastrucci; Maria Masocco; Valentina Minardi; Valentina Possenti; Giovanna Mereu; Rossella Cecconi; Guglielmo Bonaccorsi
Journal:  Int J Environ Res Public Health       Date:  2022-06-06       Impact factor: 4.614

2.  Hepatitis vaccination adherence and completion rates and factors associated with low compliance: A claims-based analysis of U.S. adults.

Authors:  Joyce LaMori; Xue Feng; Christopher D Pericone; Marco Mesa-Frias; Obiageli Sogbetun; Andrzej Kulczycki
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

3.  Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations.

Authors:  Timothy L Wiemken; Joanne Salas; John E Morley; Daniel F Hoft; Christine Jacobs; Jeffrey F Scherrer
Journal:  J Am Geriatr Soc       Date:  2021-12-12       Impact factor: 7.538

4.  Vaccinations Status against Vaccine-Preventable Diseases and Willingness to Be Vaccinated in an Italian Sample of Frail Subjects.

Authors:  Caterina De Sarro; Rosa Papadopoli; Maria Carmela Morgante; Carmelo Giuseppe Angelo Nobile; Giovambattista De Sarro; Claudia Pileggi
Journal:  Vaccines (Basel)       Date:  2022-08-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.